Benchling stock
Private-market facts for current and former Benchling employees researching their stock.
Overview
Benchling is a private company in the Healthcare & Biotech sector. This page summarizes key facts for current and former employees researching their stock.
Benchling outlook
For employees evaluating Benchling equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Benchling shares
Why shareholders consider selling
Shareholders in Benchling may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Benchling does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Benchling stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Benchling shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Benchling shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Benchling shareholders
Exploring equity in Benchling often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Benchling's latest funding details have not been publicly disclosed.
Lead investors in this round include Andreessen Horowitz and Benchmark.
Investors
Industry
Similar private companies
Latest Benchling news
Frequently asked questions
- Is Benchling still a private company?
- Yes, Benchling is currently a private company.
- What is Benchling's latest funding round?
- The latest funding round has not been publicly disclosed.
- What is Benchling's valuation?
- Benchling's valuation has not been publicly disclosed.
- Who are the investors in Benchling?
- Notable investors include Andreessen Horowitz, Benchmark, Thrive Capital, Menlo Ventures, Y Combinator, BOND.
- Can I sell my Benchling stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Benchling stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Benchling data compiled from investor announcements, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.